Maryam Asgari, MD

Professor, Dermatology

Faculty Photo
Medical School
  • MD, Yale University School of Medicine (1997)
Graduate School
  • MPH, University of Washington (2003)
Undergraduate School
  • BS, Stanford University (CA) (1992)
  • AB, Stanford University (CA) (1992)
Internship
  • Beth Israel Deaconess Medical Center Program (1998)
Residency
  • University of Washington Program, Dermatology (2002)
Fellowships
  • University of Texas Southwestern Medical School Program, Procedural Dermatology (2005)
Department
Dermatology

Professional Titles

  • Professor and Chair of Dermatology

Recognitions

  • Founder's Award, Dermatoepidemiology Network (2024)
    Awarded for lifetime achievement in the field of dermatoepidemiology.
  • Excellence in Innovation, Massachusetts General Hospital - Harvard Medical School (2017)
    Awarded for innovative in skin cancer detection.

Research Interests

I am a physician-scientist trained in Mohs micrographic surgery who specializes in skin cancer management. I dedicate my time to clinical research focused on skin cancer risk and outcomes.

Publications

  • Tan AJ, Archila M, Barbieri JS, Mostaghimi A, Scherer AM, Perez-Chada LM, Asgari MM, Gelfand JM, Noe MH. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study. Arch Dermatol Res. 2024 Apr 18;316(5):125. PubMed PMID: 38637431
  • Safaei Jazi S, Faniayeu I, Cichelero R, Tzarouchis DC, Asgari MM, Dmitriev A, Fan S, Asadchy V. Optical Tellegen metamaterial with spontaneous magnetization. Nat Commun. 2024 Feb 12;15(1):1293. PubMed PMID: 38346950
  • Lee T, George CD, Jiang C, Asgari MM, Nijsten T, Pardo LM, Choquet H. Association between lifetime smoking and cutaneous squamous cell carcinoma: A 2-sample Mendelian randomization study. JAAD Int. 2024 Mar;14:69-76. PubMed PMID: 38274396
  • Choquet H, Jiang C, Yin J, Kim Y, Hoffmann TJ, Jorgenson E, Asgari MM. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. Commun Biol. 2024 Jan 5;7(1):33. PubMed PMID: 38182794
  • George CD, Lee T, Hollestein LM, Asgari MM, Nijsten T. Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis. Br J Dermatol. 2024 Mar 15;190(4):465-476. PubMed PMID: 37890083
  • Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2024 Feb;90(2):288-298. PubMed PMID: 37797836
  • Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2024 Feb;90(2):288-298. PubMed PMID: 37797836
  • Choquet H, Jiang C, Yin J, Kim Y, Hoffmann TJ, Jorgenson E, Asgari MM. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. Commun Biol. 2024 Jan 5;7(1):33. PubMed PMID: 38182794
  • George CD, Lee T, Hollestein L, Asgari MM, Nijsten T. The Global Epidemiology of Actinic Keratosis in the General Population: A Systematic Review and Meta-Analysis. Br J Dermatol. 2023 Oct 27. [Epub ahead of print] PubMed PMID: 37890083
  • Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 Jul;112(1):E27-E29. PubMed PMID: 37611292
  • Ashrafzadeh S, Foreman RK, Kalra S, Mandinova A, Asgari MM. Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize. JAMA Dermatol. 2023 Jul 1;159(7):788-790. PubMed PMID: 37256610
  • Asgari MM, Crane LA. Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research. JAMA. 2023 Apr 18;329(15):1259-1260. PubMed PMID: 37071108
  • Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 Apr;143(4):664-667. PubMed PMID: 36343677
  • Noe MH, Archila M, Barbieri JS, Goldman N, Lopez CG, Mostaghimi A, Scherer AM, Tan AJ, Perez-Chada LM, Asgari MM, Gelfand JM. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023 Aug;315(6):1583-1592. PubMed PMID: 36749390
  • Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 Mar 10;13(3):e071172. PubMed PMID: 36898743
  • Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 Apr;143(4):664-667. PubMed PMID: 36343677
  • Noe MH, Archila M, Barbieri JS, Goldman N, Lopez CG, Mostaghimi A, Scherer AM, Tan AJ, Perez-Chada LM, Asgari MM, Gelfand JM. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023 Aug;315(6):1583-1592. PubMed PMID: 36749390
  • Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 Mar 10;13(3):e071172. PubMed PMID: 36898743
  • Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 Jul;112(1):E27-E29. PubMed PMID: 37611292
  • Ashrafzadeh S, Foreman RK, Kalra S, Mandinova A, Asgari MM. Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize. JAMA Dermatol. 2023 Jul 1;159(7):788-790. PubMed PMID: 37256610
  • Asgari MM, Crane LA. Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research. JAMA. 2023 Apr 18;329(15):1259-1260. PubMed PMID: 37071108
View All (21 Total) View Less

Practice Locations

UCHealth Dermatology Clinic - Anschutz Medical Campus
1665 Aurora Ct
3rd Floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-0500

CU Medicine Dermatology - Montview Blvd (CU Medicine Building)
13199 E Montview Blvd Ste 300
Aurora, CO 80045
(303) 315-5085

Specialty Information

Specialties
  • Dermatology, Board Certification (2002, 2022)
  • Mohs Surgery, Board Certification (2024)
  • Procedural Dermatology (Mohs), Specialized Training (2004)
Conditions & Treatments
  • Cancers - Skin Cancer
  • Cancers
Clinical Interests
Squamous cell carcinoma, basal cell carcinoma, Merkel cell carcinoma, melanoma.

Care Philosophy
I have a holistic view of patient care delivery which involves attention and care to the whole individual, not just their skin cancer. I strive to make my patients feel welcome, relaxed and professionally cared for during their time with me.

School of Medicine

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Campus Box C290

Aurora, CO 80045


303.724.5375